Zoetis Inc. (ZTS)

Acerca de Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Al 3 de noviembre de 2026, la acción de Zoetis Inc. (ZTS) subió a $83.67, un alza de 0.58% (+$0.48) frente al cierre anterior. En la sesión, las acciones han operado entre $81.53 y $83.73. Eso ubica a ZTS en el tercio inferior de su rango de 52 semanas, de $68.77 a $132.49. Zoetis Inc. opera en el sector de pharmaceutical preparations y tiene una capitalización de mercado de aproximadamente $32.94 mil millones, con cerca de 906.1 mil acciones negociadas.

Últimas noticias de ZTS

• Zoetis Gears Up to Report Q3 Earnings: Here's What to ExpectYahoo Finance· 3 nov, 9:15 a.m. ET
• Insights Into Zoetis (ZTS) Q3: Wall Street Projections for Key MetricsYahoo Finance· 3 nov, 8:15 a.m. ET
• Amneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Top EstimatesYahoo Finance· 3 nov, 6:25 a.m. ETAMRX
• 1 healthcare stock with impressive fundamentals and 2 we ignoreYahoo Finance· 3 nov, 6:09 a.m. ET
• IDEXX Soars 20% on Beat-and-Raise Quarter: “Early Innings of a Broad-Based Innovation Cycle”tikr.com· 2 nov, 1:32 p.m. ET
• 4D Molecular Therapeutics, Inc. (FDMT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Yahoo Finance· 2 nov, 9:00 a.m. ETFDMT
• IDEXX Laboratories Reports Soon: How Has The Stock Reacted To Past Earnings?trefis.com· 30 oct, 5:57 a.m. ETIDXX
• Zoetis (ZTS) Ascends While Market Falls: Some Facts to NoteYahoo Finance· 29 oct, 5:15 p.m. ET

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de ZTS en un solo lugar? Crea una cuenta gratis →

• $ZTS reports Thursday before the open, and the category table in its last 10-Q shows a pretty lopsided mix heading in. Dermatology revenue fell to 398 million dollars in Q2 from 473 million a year earlier, and pain and sedation slipped to 217 million from 223 million, while pa…

  @KryptonResearch14· 3 nov, 12:04 a.m. ET

• $ZTS Really good write-up that perfectly summarizes ZTS's present situation. So if you want to bring your ZTS knowledge up to date or just discover ZTS, this is required reading. https://everyticker.com/quote/ZTS/analysis/zoetis-companion-animal-margin-compression-tests-a-…

  @NVDAMillionaire· 2 nov, 3:43 a.m. ET

• $ZTS not that the market cares about my dog lmao but cytopoint is so much better than apoquel. Take doggo for the shot and you don’t have to give a pill every day

  @inthegrove· 30 oct, 2:38 p.m. ET· Alcista

• $ZTS Compared to anything AI related the stock is cheap. I dont think its a home run from here with this debt, but a single

  @OffHisGame88· 30 oct, 11:06 a.m. ET

• $ZTS closed for 10% reenter sub 70

  @Doornumber3· 28 oct, 3:48 p.m. ET

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →